A case of high‐risk <scp>AML</scp> in a patient with advanced systemic mastocytosis-Reference-Cited by-同舟云学术

A case of high‐risk AML in a patient with advanced systemic mastocytosis

Published:2023-07 Issue:7 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Fazio Manlio¹^ORCID,Vetro Calogero²,Markovic Uroš²^ORCID,Duminuco Andrea¹,Parisi Marina²,Maugeri Cinzia²,Mauro Elisa²,Parrinello Nunziatina Laura²,Stagno Fabio²,Villari Loredana³,Triolo Anna Maria²,Stella Stefania⁴,Palumbo Giuseppe A.¹⁵⁶,Di Raimondo Francesco²⁵,Romano Alessandra⁵^ORCID,Zanotti Roberta⁷^ORCID

Affiliation:

1. Post Graduation School of Hematology University of Catania, A.O.U. Policlinico “G.Rodolico‐San Marco” Catania Italy

2. Division of Hematology A.O.U. Policlinico “G.Rodolico‐San Marco” Catania Italy

3. Department of Pathology A.O.U. Policlinico di Catania Catania Italy

4. Center of Experimental Oncology and Hematology A.O.U. Policlinico “G. Rodolico‐San Marco” Catania Italy

5. Dipartimento di specialità Medico‐Chirurgiche, CHIRMED, sezione di Ematologia Università degli Studi di Catania Catania Italy

6. Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia” University of Catania Catania Italy

7. Department of Medicine, Hematology Unit Azienda Ospedaliera Universitaria Integrata di Verona Verona Italy

Abstract

AbstractAggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine–venetoclax–midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7134

Reference28 articles.

1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

2. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy

3. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management

4. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midostaurin;Reactions Weekly;2024-03-09

2. Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts;International Journal of Molecular Sciences;2023-10-12